Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients

Conclusions: Our study suggests that the CAV/IE alternating regimen may be associated with a better response and more favorable survival than the MAID (AI) regimen in advanced soft-tissue sarcoma patients. Furthermore, the CREB3L1 expression level may predict the efficacy and survival of doxorubicin-based palliative chemotherapy for advanced soft-tissue sarcoma.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Wei Xiao, Yao Liang, Yi Que, Jingjing Li, Ruiqing Peng, Bushu Xu, Xizhi Wen, Jingjing Zhao, Yuanxiang Guan, Xing Zhang Tags: Research Paper Source Type: research